Clinical Trial

Atrioventricular Nodal Ablation Versus Pulmonary Vein Isolation - Patient Centred Decisions

Study acronym: AVENUE PACE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to compare two procedural approaches to managing atrial fibrillation. The main questions it aims to answer are: Is AF ablation or pacemaker implant and AV nodal ablation a more effective treatment approach for patients with atrial fibrillation refractory to pharmacological treatment? What effect do these differing treatment approaches have on patient's quality of life and mental health? Participants will: Be randomly allocated to one of the treatment approaches. Visit the clinic 2 months, 12 months and 24 months after their procedure for a checkup, questionnaires and repeat heart ultrasounds.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-01.
Trial Details
NCT Number NCT07059208
Lead Sponsor Sunshine Coast Hospital and Health Service
Conditions Atrial Fibrillation (AF)
Enrollment 172 participants
Start Date 2025-09
Primary Completion 2029-09 (estimated)
Study Completion 2031-09 (estimated)
Updated on ClinicalTrials.gov 2025-07-14